Logo image of BKV

BKV CORPORATION (BKV) Stock Fundamental Analysis

NYSE:BKV - New York Stock Exchange, Inc. - US05603J1088 - Common Stock - Currency: USD

23.02  +0.81 (+3.65%)

Fundamental Rating

2

Overall BKV gets a fundamental rating of 2 out of 10. We evaluated BKV against 211 industry peers in the Oil, Gas & Consumable Fuels industry. BKV may be in some trouble as it scores bad on both profitability and health. BKV is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BKV had negative earnings in the past year.
BKV had a positive operating cash flow in the past year.
BKV Yearly Net Income VS EBIT VS OCF VS FCFBKV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

1.2 Ratios

Looking at the Return On Assets, with a value of -8.13%, BKV is doing worse than 81.04% of the companies in the same industry.
BKV has a Return On Equity of -12.35%. This is in the lower half of the industry: BKV underperforms 74.41% of its industry peers.
Industry RankSector Rank
ROA -8.13%
ROE -12.35%
ROIC N/A
ROA(3y)4.38%
ROA(5y)N/A
ROE(3y)11%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BKV Yearly ROA, ROE, ROICBKV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 -10 20 -20 30

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BKV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BKV Yearly Profit, Operating, Gross MarginsBKV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20

More info and screens

2

2. Health

2.1 Basic Checks

BKV does not have a ROIC to compare to the WACC, probably because it is not profitable.
BKV has more shares outstanding than it did 1 year ago.
BKV has a better debt/assets ratio than last year.
BKV Yearly Shares OutstandingBKV Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
BKV Yearly Total Debt VS Total AssetsBKV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

BKV has an Altman-Z score of 1.31. This is a bad value and indicates that BKV is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.31, BKV perfoms like the industry average, outperforming 50.24% of the companies in the same industry.
BKV has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.13, BKV is doing good in the industry, outperforming 73.93% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z 1.31
ROIC/WACCN/A
WACC9.7%
BKV Yearly LT Debt VS Equity VS FCFBKV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

BKV has a Current Ratio of 0.41. This is a bad value and indicates that BKV is not financially healthy enough and could expect problems in meeting its short term obligations.
BKV has a worse Current ratio (0.41) than 90.05% of its industry peers.
A Quick Ratio of 0.39 indicates that BKV may have some problems paying its short term obligations.
The Quick ratio of BKV (0.39) is worse than 89.57% of its industry peers.
Industry RankSector Rank
Current Ratio 0.41
Quick Ratio 0.39
BKV Yearly Current Assets VS Current LiabilitesBKV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

4

3. Growth

3.1 Past

BKV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -244.20%.
The Revenue for BKV has decreased by -41.68% in the past year. This is quite bad
The Revenue has been growing slightly by 4.09% on average over the past years.
EPS 1Y (TTM)-244.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-102.46%
Revenue 1Y (TTM)-41.68%
Revenue growth 3Y4.09%
Revenue growth 5YN/A
Sales Q2Q%-47.88%

3.2 Future

The Earnings Per Share is expected to grow by 54.85% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 18.02% on average over the next years. This is quite good.
EPS Next Y193.05%
EPS Next 2Y81.79%
EPS Next 3Y54.85%
EPS Next 5YN/A
Revenue Next Year17.02%
Revenue Next 2Y24.76%
Revenue Next 3Y18.02%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BKV Yearly Revenue VS EstimatesBKV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
BKV Yearly EPS VS EstimatesBKV Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 1 -1 2

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BKV. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 12.40, the valuation of BKV can be described as correct.
The rest of the industry has a similar Price/Forward Earnings ratio as BKV.
BKV is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 12.4
BKV Price Earnings VS Forward Price EarningsBKV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BKV Per share dataBKV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

BKV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BKV's earnings are expected to grow with 54.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y81.79%
EPS Next 3Y54.85%

More info and screens

0

5. Dividend

5.1 Amount

BKV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BKV CORPORATION

NYSE:BKV (7/2/2025, 3:59:59 PM)

23.02

+0.81 (+3.65%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)N/A N/A
Inst Owners19.48%
Inst Owner Change0.94%
Ins Owners4.57%
Ins Owner Change-2.82%
Market Cap1.95B
Analysts85
Price Target28.82 (25.2%)
Short Float %6.9%
Short Ratio3.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)135.83%
Min EPS beat(2)106.59%
Max EPS beat(2)165.08%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-49.23%
Min Revenue beat(2)-63.18%
Max Revenue beat(2)-35.28%
Revenue beat(4)0
Avg Revenue beat(4)-29.29%
Min Revenue beat(4)-63.18%
Max Revenue beat(4)-3.43%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.11%
PT rev (3m)-0.29%
EPS NQ rev (1m)-18.34%
EPS NQ rev (3m)8.62%
EPS NY rev (1m)-19.91%
EPS NY rev (3m)19.68%
Revenue NQ rev (1m)3.37%
Revenue NQ rev (3m)15.25%
Revenue NY rev (1m)-7.15%
Revenue NY rev (3m)-6.24%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.4
P/S 3.92
P/FCF N/A
P/OCF 16
P/B 1.32
P/tB 1.33
EV/EBITDA N/A
EPS(TTM)-2.14
EYN/A
EPS(NY)1.86
Fwd EY8.07%
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)1.44
OCFY6.25%
SpS5.88
BVpS17.49
TBVpS17.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.13%
ROE -12.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)4.38%
ROA(5y)N/A
ROE(3y)11%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 67.6%
Cap/Sales 27.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.41
Quick Ratio 0.39
Altman-Z 1.31
F-Score3
WACC9.7%
ROIC/WACCN/A
Cap/Depr(3y)107.23%
Cap/Depr(5y)N/A
Cap/Sales(3y)20.42%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-244.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-102.46%
EPS Next Y193.05%
EPS Next 2Y81.79%
EPS Next 3Y54.85%
EPS Next 5YN/A
Revenue 1Y (TTM)-41.68%
Revenue growth 3Y4.09%
Revenue growth 5YN/A
Sales Q2Q%-47.88%
Revenue Next Year17.02%
Revenue Next 2Y24.76%
Revenue Next 3Y18.02%
Revenue Next 5YN/A
EBIT growth 1Y-206.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year522.34%
EBIT Next 3Y85.79%
EBIT Next 5YN/A
FCF growth 1Y125.8%
FCF growth 3Y-60.43%
FCF growth 5YN/A
OCF growth 1Y-3.69%
OCF growth 3Y-30.83%
OCF growth 5YN/A